amt-130
·Code: AMT-130
amt-130: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| uniQure N.V. (QURE) | Phase 2 |
FDA Decisions
FDA_MeetingThe FDA conveyed that data submitted from the Phase I/II studies of AMT-130 are currently unlikely to provide the primary evidence to support a BLA submission.(QURE)
Frequently asked questions
Who is developing amt-130?
amt-130 is being developed by uniQure N.V..
What is amt-130's latest FDA decision?
The most recent tracked FDA decision for amt-130 is FDA_Meeting for The FDA conveyed that data submitted from the Phase I/II studies of AMT-130 are currently unlikely to provide the primary evidence to support a BLA submission., dated October 29, 2025.
Get deeper analysis on amt-130
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis